Bender J F, Fortner C L, Schimpff S C, Grove W R, Hahn D M, Love L J, Wiernik P H
Am J Hosp Pharm. 1979 Aug;36(8):1083-7.
The incidence of auditory toxicity resulting from therapy with ticarcillin (T) (12 g/sq m/day) in combination with gentamicin (G) (200 mg/sq m/day), amikacin (A) (600 mg/dq m/day), or netilmicin (N) (280 mg/sq m/day) was compared. Before administration of these antibiotic combinations to febrile, granulocytopenic patients, baseline audiograms were determined by a pharmacist using a portable audiometer. The before-therapy audiograms for 32 patients receiving T and G, 29 receiving T and A, and 29 receiving T and N were compared with the audiograms after the completion of therapy. The mean length of therapy was seven days. Two patients (6.2%) receiving T and G, one (3.4%) receiving T and N, and one (3.4%) receiving T and A developed auditory toxicity with bilateral decreases of at least 20 decibels at one or more frequencies. The incidence of auditory toxicity secondary to aminoglycoside exposure was low, and the relative auditory toxicity among the three aminoglycosides appeared to be similar.
比较了替卡西林(T)(12 g/平方米/天)与庆大霉素(G)(200 mg/平方米/天)、阿米卡星(A)(600 mg/平方米/天)或奈替米星(N)(280 mg/平方米/天)联合治疗导致听觉毒性的发生率。在对发热、粒细胞减少的患者使用这些抗生素组合之前,由药剂师使用便携式听力计测定基线听力图。将32例接受T和G、29例接受T和A、29例接受T和N治疗的患者治疗前的听力图与治疗结束后的听力图进行比较。平均治疗时长为7天。2例(6.2%)接受T和G、1例(3.4%)接受T和N、1例(3.4%)接受T和A的患者出现听觉毒性,在一个或多个频率上双侧听力下降至少20分贝。氨基糖苷类药物暴露继发的听觉毒性发生率较低,三种氨基糖苷类药物之间的相对听觉毒性似乎相似。